Registered Office:
#DPT-033 Gr Flr Plt #79-80 DLF,Prime Tower F Blo.Okhla Phase1,
New Delhi -
110020,
New Delhi, India.
Phone : +91-11 4656 1474 Fax:
Email : cs@mahamayalifesciences.com
Website : https://www.mahamayalifesciences.com/
|
| Initial public offer of up to 61,78,800 equity shares of face value of (Rs) 10/- each ("equity shares") of Mahamaya Lifesciences Limited ("MLL" or the "company") for cash at price of (Rs) 114/- per equity share (including a share premium of 104/- per equity share) (the "offer price"), aggregating up to (Rs) 70.44 crores ("the offer"), comprising a fresh offer of upto 56,38,800 equity shares aggregating to (Rs) 64.28 crores (the "fresh offer") and an offer for sale of upto 5,40,000 equity shares (the "offered shares") of face value of (Rs) 10/- each aggregating up to (Rs) 6.16 crores ("offer for sale") comprising of 3,70,000 equity shares aggregating up to (Rs) 4.22 crores by Krishnamurthy Ganesan and 1,70,000 equity shares aggregating up to (Rs) 1.94 crores by Lalitha Krishnamurthy (collectively referred to as the "selling shareholders") out of which 3,09,600 equity shares of face value of (Rs) 10/- each, at an offer price of (Rs) 114/- per equity share for cash, aggregating up to (Rs) 3.53 crores will be reserved for subscription by the market maker to the offer ( the "market maker reservation portion"). The offer less market maker reservation portion i.e. net offer of 58,69,200 equity shares of face value of (Rs) 10/- each, at an offer price of (Rs) 114/- per equity share for cash, aggregating up to (Rs) 66.91 crores is hereinafter referred to as the "net offer". The offer and net offer will constitute 26.40% and 25.08% respectively of the post-offer paid-up equity share capital of the company. The price band and the minimum bid lot will be decided by the company. |
|
| Issue |
Money Payable On |
| Opens On |
Closes On |
Application |
Allotment |
| 11-Nov-25 |
13-Nov-25 |
114.00-0.00 |
0.00-0.00 |
|
|
Minimum Application for shares in Nos :
2400
Further Multiples of :
1200
|
|
| |
(Rs.Cr) |
Lead Managers to the Issue |
| Project Cost |
61.96 |
Oneview Corporate Advisors Pvt Ltd
|
| Project Financed through Current Offer |
70.44 |
|
| Post Issue Equity Share Capital |
23.41 |
|
| Issue Price |
114.00 |
|
|